Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Dal Corso

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Chembiochem : a European Journal of Chemical Biology|September 7, 2020
Targeted Small-Molecule Conjugates: The Future is NowAlberto Dal Corso
Molecular Cancer Therapeutics|September 10, 2016
Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell CarcinomaSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Chimia|October 27, 2017
Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New DevelopmentsSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 29, 2016
Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinomaSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 17, 2019
Innovative Linker Strategies for Tumor-Targeted Drug ConjugatesAlberto Dal Corso, Luca Pignataro, Laura Belvisi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 4, 2026
Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction PerformanceLuigi Dolcini, Daniele Lavelli, Alberto Dal Corso, et al.
Current Topics in Medicinal Chemistry|July 2, 2015
αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker TechnologyAlberto Dal Corso, Luca Pignataro, Laura Belvisi, et al.
Chembiochem : a European Journal of Chemical Biology|November 21, 2023
A Tight Contact: The Expanding Application of Salicylaldehydes in Lysine-Targeting Covalent DrugsMattia Mason, Laura Belvisi, Luca Pignataro, et al.
Journal of the American Chemical Society|January 18, 2018
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative AnalysisSamuele Cazzamalli, Alberto Dal Corso, Fontaine Widmayer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2017
A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivoAlberto Dal Corso, Rémy Gébleux, Patrizia Murer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Chembiochem : a European Journal of Chemical Biology|September 7, 2020
Targeted Small-Molecule Conjugates: The Future is NowAlberto Dal Corso
Molecular Cancer Therapeutics|September 10, 2016
Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell CarcinomaSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Chimia|October 27, 2017
Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New DevelopmentsSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 29, 2016
Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinomaSamuele Cazzamalli, Alberto Dal Corso, Dario Neri
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 17, 2019
Innovative Linker Strategies for Tumor-Targeted Drug ConjugatesAlberto Dal Corso, Luca Pignataro, Laura Belvisi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 4, 2026
Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction PerformanceLuigi Dolcini, Daniele Lavelli, Alberto Dal Corso, et al.
Current Topics in Medicinal Chemistry|July 2, 2015
αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker TechnologyAlberto Dal Corso, Luca Pignataro, Laura Belvisi, et al.
Chembiochem : a European Journal of Chemical Biology|November 21, 2023
A Tight Contact: The Expanding Application of Salicylaldehydes in Lysine-Targeting Covalent DrugsMattia Mason, Laura Belvisi, Luca Pignataro, et al.
Journal of the American Chemical Society|January 18, 2018
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative AnalysisSamuele Cazzamalli, Alberto Dal Corso, Fontaine Widmayer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2017
A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivoAlberto Dal Corso, Rémy Gébleux, Patrizia Murer, et al.
Pageof 4